180 related articles for article (PubMed ID: 1666894)
1. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Nixon JS; Bottomley KM; Broadhurst MJ; Brown PA; Johnson WH; Lawton G; Marley J; Sedgwick AD; Wilkinson SE
Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
4. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
5. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
6. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
7. Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo.
Lewis EJ; Bishop J; Bottomley KM; Bradshaw D; Brewster M; Broadhurst MJ; Brown PA; Budd JM; Elliott L; Greenham AK; Johnson WH; Nixon JS; Rose F; Sutton B; Wilson K
Br J Pharmacol; 1997 Jun; 121(3):540-6. PubMed ID: 9179398
[TBL] [Abstract][Full Text] [Related]
8. Role of metalloproteinases in human osteoarthritis.
Woessner JF; Gunja-Smith Z
J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
Milner JM; Rowan AD; Elliott SF; Cawston TE
Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
[TBL] [Abstract][Full Text] [Related]
10. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
11. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown.
Cai L; Suboc P; Hogue DA; Fei DT; Filvaroff EH
J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
Girard MT; Matsubara M; Fini ME
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
[TBL] [Abstract][Full Text] [Related]
16. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
[TBL] [Abstract][Full Text] [Related]
17. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
19. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
[TBL] [Abstract][Full Text] [Related]
20. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
Homandberg GA; Hui F
Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
